600056 中國醫藥
按盤價 
10.360 -0.040 (-0.385%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.528 | 3.966 | 4.939 | 9.368 | 6.982 |
| 總資產報酬率 ROA (%) | 0.490 | 1.293 | 1.580 | 2.859 | 2.196 |
| 投入資產回報率 ROIC (%) | 0.809 | 2.078 | 2.539 | 4.734 | 3.594 | 邊際利潤分析 |
| 銷售毛利率 (%) | 10.610 | 10.502 | 10.736 | 11.291 | 12.627 |
| 營業利潤率 (%) | 3.819 | 2.893 | 2.799 | 4.307 | 3.191 |
| 息稅前利潤/營業總收入 (%) | 4.198 | 3.137 | 3.461 | 4.514 | 3.550 |
| 淨利潤/營業總收入 (%) | 2.896 | 1.908 | 2.082 | 3.199 | 2.363 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 98.308 | 125.012 | 121.416 | 80.615 | 121.618 |
| 價值變動淨收益/利潤總額(%) | 2.423 | -7.027 | 6.288 | -0.903 | 4.425 |
| 營業外收支淨額/利潤總額(%) | 0.499 | -2.371 | 2.139 | -1.937 | -0.299 | 償債能力分析 |
| 流動比率 (X) | 1.423 | 1.423 | 1.523 | 1.584 | 1.495 |
| 速動比率 (X) | 1.111 | 1.116 | 1.174 | 1.238 | 1.158 |
| 資產負債率 (%) | 61.041 | 61.044 | 60.558 | 62.877 | 63.312 |
| 帶息債務/全部投入資本 (%) | 37.260 | 37.482 | 37.757 | 35.645 | 38.609 |
| 股東權益/帶息債務 (%) | 142.009 | 141.545 | 137.049 | 143.241 | 129.484 |
| 股東權益/負債合計 (%) | 52.534 | 52.587 | 54.687 | 49.147 | 47.581 |
| 利息保障倍數 (X) | 11.675 | 10.083 | 5.767 | 15.643 | 9.648 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 164.005 | 138.467 | 137.172 | 125.141 | 116.446 |
| 存貨周轉天數 (天) | 75.422 | 70.256 | 71.590 | 64.366 | 64.338 |
| 備註： | 即時報價更新時間為 30/04/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
